Content about DSN AM

SAN FRANCISCO — Users of McKesson's EnterpriseRx pharmacy system can communicate with patients through several mobile communication pathways and deliver a full-featured mobile pharmacy system using the mScripts mobile pharmacy platform, mScripts said Tuesday.

The company said it had received certification for the system, following its announcement of the integration with EnterpriseRx last week.

MADISON, N.J. — The Natural Dentist has launched “Rinse for Relief,” an online resource for proper oral care aimed at cancer patients suffering from mouth sores and other oral ailments, the fourth most common side effect of chemotherapy treatments. The initiative included the unveiling of RinseForRelief.com and a giveaway of one free sample of Healthy Gums Mouth Rinse, an all-natural product that works as an effective daily cleanser and helps prevent and reduce gum bleeding and inflammation.

NEW YORK — A ruling by India's high court means cheaper generic versions of a cancer drug will remain available in developing countries, according to published reports.

The New York Times reported that the Indian Supreme Court ruled drug companies there could keep making generic versions of Swiss drug maker Novartis' leukemia medication Gleevec (imatinib). According to the Times, generic versions of Gleevec in India cost about $2,500 per year, compared with $70,000 per year for the branded version.

NEW ORLEANS — A coalition of drug and pharmacy organizations formed to address patients' medication needs during disasters is changing the name and Web address of its reporting system to make it easier to remember, the organization said Tuesday.

SAN DIEGO — Specialty drugs are expected to account for 50% of all drug costs by 2018, according to two new studies.

By contrast, specialty drugs accounted for 20% of all drug costs in 2009, but increased to 28.7% by 2012. Pharmacy benefit manager Prime Therapeutics and Blue Cross and Blue Shield of Minnesota conducted the studies, and Prime is presenting them Tuesday at the Academy of Managed Care Pharmacy's 25th annual meeting and expo in San Diego.

NEW YORK — The L'Oréal-Unesco For Women in Science program awarded five women scientists from around the world with the 2013 L'Oréal-Unesco Awards in the Physical Sciences.

CARLISLE, Pa. — Ahold USA now has the largest number of stores that have received leadership in energy and environmental design certification from the U.S. Green Building Council, the supermarket operator said Tuesday.

DEERFIELD, Ill. — Walgreens on Tuesday announced that walking, running and weight-management goals can be logged and tracked through Steps with Balance Rewards, the retailer's customer loyalty program. Members will receive 20 points per mile, as well as 20 points per day for tracking their weight. Users also can log individual frequent activities that will earn points when recorded. Additionally, members can sync wireless activity trackers such as Fitbit, Withings and BodyMedia to automatically load the number of steps taken — each device linked will earn 250 points.

PARSIPPANY, N.J. — Just a week after the Supreme Court heard the Federal Trade Commission's lawsuit over its deal with AbbVie to sell a generic version of a testosterone-replacement therapy, Actavis is challenging the patent on another strength of the drug.

Actavis said Monday that it had filed with the Food and Drug Administration for approval of testosterone gel in the 1.62% strength. The drug is a generic version of AbbVie's AndroGel 1.62%. The case that went before the Supreme Court on March 25 concerns the 1% strength of AndroGel.

WOONSOCKET, R.I. — CVS Caremark elected on March 29 former Johnson & Johnson CEO William Weldon to serve on its board of directors, according to a filing with the Securities and Exchange Commission.

Weldon is the former chairman of the board and CEO of Johnson & Johnson, having served in those positions from 2002 until his retirement as CEO in April 2012 and his retirement from the board in December 2012. Weldon previously served in a variety of senior executive positions during his 41-year career with J&J.

JERUSALEM — The Food and Drug Administration has approved a new contraceptive therapy made by Teva Pharmaceutical Industries, Teva said Monday.

The drug maker announced the approval of Quartette (levonorgestrel, ethinyl estradiol and ethinyl estradiol) tablets. Teva said the drug represented the "next generation" of extended-regimen oral contraceptives and was designed to minimize breakthrough bleeding between scheduled periods.

ANN ARBOR, Mich. — Symptoms associated with gastroesophageal reflux disease are frequently overtreated in infants, according to a new study by researchers in Michigan and Missouri.

The study, published online Monday in the journal Pediatrics, found that doctors often diagnose such common symptoms in infants as crying and spitting up as disease, and frequent diagnoses of GERD can lead to overuse of medications to treat it, said the researchers at the University of Michigan and the University of Missouri.